JEFFREY YORDON

Insider Reports History

Signature
/s/Staci Holquist, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JEFFREY YORDON:

Company Role Class Num Shares Value Price $ Report Date Ownership
Athenex, Inc. COO, and President, Athenex Pharmaceutical Division. Common Stock 245,943 $334,482 $1.36 03 Aug 2022 Direct
Athenex, Inc. COO, and President, Athenex Pharmaceutical Division. Stock Option (Right to Buy) 150,000 03 Aug 2022 Direct
Athenex, Inc. COO, and President, Athenex Pharmaceutical Division. Restricted Stock Units 37,500 03 Aug 2022 Direct

Insider Reports Filed by JEFFREY YORDON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919122045835-yordon-jeffrey-2022-08-03 Athenex, Inc. 03 Aug 2022 3 -$2,127 4 COO, and President, Athenex Pharmaceutical Division. 15 Aug 2022, 17:34
/report/000120919122042905-yordon-jeffrey-2022-07-20 Athenex, Inc. 20 Jul 2022 1 $0 4 COO, and President, Athenex Pharmaceutical Division. Exhibit List: Exhibit 24.1 - Power of Attorney 21 Jul 2022, 17:40
/report/000120919121049959-yordon-jeffrey-2021-08-03 Athenex, Inc. 03 Aug 2021 2 $0 4 COO, and President, Athenex Pharmaceutical Division. 05 Aug 2021, 16:49